Skip to main content

Find Clinical Trials

Home
Conditions
Meningeal Neoplasms

Clinical trial condition

Meningeal Neoplasms

Explore clinical trials studying Meningeal Neoplasms. Study availability and eligibility vary by location and protocol.

271 public trials 86 recruiting studies

Refine in advanced search Browse all conditions

Meningeal Neoplasms trial results

Completed

Topotecan Hydrochloride in Treating Children With Meningeal Cancer That Has Not Responded to Previous Treatment

NCT00005811

Conditions: AIDS-related Diffuse Large Cell Lymphoma, AIDS-related Diffuse Mixed Cell Lymphoma, AIDS-related Diffuse Small Cleaved Cell Lymphoma, +60 more
Locations: Children's Oncology Group Arcadia, California, United States

View Trial Details

Completed

Melphalan in Patients With Neoplastic Meningitis

NCT00002750

Conditions: Adnexal Diseases, Blood Protein Disorders, Brain and Central Nervous System Tumors, +66 more
Locations: Duke Comprehensive Cancer Center Durham, North Carolina, United States

View Trial Details

Completed

LMB-7 Immunotoxin in Treating Patients With Leptomeningeal Metastases

NCT00003020

Conditions: Brain and Central Nervous System Tumors, Central Nervous System Neoplasms, Meningeal Carcinomatosis, +5 more
Locations: Duke Comprehensive Cancer Center Durham, North Carolina, United States

Kimmel Cancer Center of Thomas Jefferson University - Philadelphia Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Intrathecal Busulfan in Treating Patients With Recurrent, Refractory, or Metastatic Leptomeningeal Tumors

NCT00003462

Conditions: Brain and Central Nervous System Tumors, Central Nervous System Neoplasms, Meningeal Carcinomatosis, +5 more
Locations: Duke Comprehensive Cancer Center Durham, North Carolina, United States

View Trial Details

Completed

Bortezomib and Temozolomide in Treating Patients With Brain Tumors or Other Solid Tumors That Have Not Responded to Treatment

NCT00544284

Conditions: Astrocytoma, Brain Diseases, Brain Neoplasms, +40 more
Locations: City of Hope Comprehensive Cancer Center Duarte, California, United States

City of Hope Medical Group Pasadena, California, United States

View Trial Details

Completed

Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer

NCT00005842

Conditions: Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +135 more
Locations: Brooke Army Medical Center Fort Sam Houston, Texas, United States

Institute for Drug Development San Antonio, Texas, United States

View Trial Details

Completed

Imatinib Mesylate and Hydroxyurea in Treating Patients With Recurrent or Progressive Meningioma

NCT00354913

Conditions: Astrocytoma, Brain Diseases, Brain Neoplasms, +18 more
Locations: Duke Cancer Institute Durham, North Carolina, United States

View Trial Details

Completed

Topotecan in Treating Patients With Recurrent, Progressive, or Refractory Cancer That is Metastatic to the Lining Around the Brain

NCT00025311

Conditions: Brain and Central Nervous System Tumors, Central Nervous System Neoplasms, Meningeal Carcinomatosis, +5 more
Locations: NYU School of Medicine's Kaplan Comprehensive Cancer Center New York, United States

Herbert Irving Comprehensive Cancer Center New York, United States

CHU Pitie-Salpetriere Paris, France

View Trial Details

Completed

Stress Reduction Program in Patients With Malignant Brain Tumors and Their Family Caregivers

NCT00376818

Conditions: Astrocytoma, Brain Diseases, Brain Neoplasms, +24 more
Locations: Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Phase 1 Intrathecal Topotecan for Neoplastic Meningitis

NCT00674674

Conditions: Central Nervous System Neoplasms, Meningeal Carcinomatosis, Meningeal Neoplasms, +7 more
Locations: Texas Children's Hospital Houston, Texas, United States

View Trial Details